The trademark application MRESYVAQ was filed by ModernaTx, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on January 19, 2023, and it was registered by office on April 28, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on August 14, 2023. Change of name and address of the trademark registration was recorded on May 14, 2024.